| Name | Alunacedase alfa |
|---|
| Description | Alunacedase alfa (HrsACE2; GSK 2586881) is a human recombinant soluble angiotensin-converting enzyme-2 (hrsACE2). Alunacedase alfa is a genetically modified soluble form of ACE2, it decreases cell entry of SARS-CoV-2 competing for membrane-bound ACE2. Alunacedase alfa has the potential for the research of SARS-CoV-2[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | Alunacedase alfa 以大约 1·2 nM 的亲和力与 SARS-CoV-2 的刺突糖蛋白结合[2]。 |
| References |
| No Any Chemical & Physical Properties |